You can help our author matching system! If you notice any publications incorrectly attributed to this author, please
sign in and mark matches as correct or incorrect.
|
Piomelli D, Scalvini L, Fotio Y, et al. (2020) N-acylethanolamine Acid Amidase (NAAA): Structure, Functions and Inhibition. Journal of Medicinal Chemistry |
Vozella V, Ahmed F, Choobchian P, et al. (2019) Pharmacokinetics, pharmacodynamics and safety studies on URB937, a peripherally restricted fatty acid amide hydrolase inhibitor, in rats. The Journal of Pharmacy and Pharmacology |
Gobbi G, Lopez-Canul M, Palazzo E, et al. (2016) PT628. First in class melatonin MT2 receptors agonists for neuropathic pain The International Journal of Neuropsychopharmacology. 19: 30-30 |
Pace S, Brogin G, Stasi MA, et al. (2015) Potent, Metabolically Stable 2-Alkyl-8-(2H-1,2,3-triazol-2-yl)-9H-adenines as Adenosine A2A Receptor Ligands. Chemmedchem |
Ribeiro A, Pontis S, Mengatto L, et al. (2015) A Potent Systemically Active N-Acylethanolamine Acid Amidase Inhibitor that Suppresses Inflammation and Human Macrophage Activation. Acs Chemical Biology |
Lopez-Canul M, Palazzo E, Dominguez-Lopez S, et al. (2015) Selective melatonin MT2 receptor ligands relieve neuropathic pain through modulation of brainstem descending antinociceptive pathways. Pain. 156: 305-17 |
Moreno-Sanz G, Barrera B, Armirotti A, et al. (2014) Structural determinants of peripheral O-arylcarbamate FAAH inhibitors render them dual substrates for Abcb1 and Abcg2 and restrict their access to the brain. Pharmacological Research : the Official Journal of the Italian Pharmacological Society. 87: 87-93 |
Fiasella A, Nuzzi A, Summa M, et al. (2014) 3-Aminoazetidin-2-one derivatives as N-acylethanolamine acid amidase (NAAA) inhibitors suitable for systemic administration. Chemmedchem. 9: 1602-14 |
Spadoni G, Bedini A, Bartolucci S, et al. (2014) Towards the development of 5-HT₇ ligands combining serotonin-like and arylpiperazine moieties. European Journal of Medicinal Chemistry. 80: 8-35 |
Ochoa-Sanchez R, Comai S, Spadoni G, et al. (2014) Melatonin, selective and non-selective MT1/MT2 receptors agonists: differential effects on the 24-h vigilance states. Neuroscience Letters. 561: 156-61 |